Skip to main content
Sign In

Philip Owens, Ph.D.

Assistant Professor

Education and Training:​​​
  • Basic Medical Specalist (91B/W)-1995 US Army
  • B.S., The Evergreen State College (1999)
  • Ph.D., Cell and Development, Oregon Health Sciences University (2008)
  • Postdoctoral, Vanderbilt Ingram Cancer Center, Vanderbuilt University (2009-2013)
Research Interests:​​​
  • The role of BMP signaling in tumor induced bone disease.
  • The role of BMP signaling in tumor associated lymphatics.
  • The role of BMP signaling in tumor associated myeloid cells.
Selected Publications: ​
  • Hover LD, Young CD, Bhola NE, Wilson AJ, Khabele D, Hong CC, Moses HL, Owens P. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Lett. 2015 Jul 30. pii: S0304-3835(15)00487-5. doi: 10.1016/j.canlet.2015.07.032. [Epub ahead of print] PMID: 26235139
  • Owens P, Pickup MW, Novitskiy SV, Giltnane JM, Gorska AE, Hopkins CR, Hong CC, Moses HL. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015 May 7;34(19):2437-49. doi: 10.1038/onc.2014.189. Epub 2014 Jul 7. PMID: 24998846.
  • Pickup MW, Hover LD, Polikowsky ER, Novitskiy SV, Gorska AE, Chytil A, Moses HL, Owens P. BMPR2 deletion in mammary fibroblasts promotes tumor growth and metastasis via alternate BMP signaling and cytokine activation.  Mol Oncol 2015 Jan;9(1):179-91. doi: 10.1016/j.molonc.2014.08.004. Epub 2014 Aug 23. PMID: 25205038
  • Pickup MW, Novitskiy SV, Chytil A, Gorska AE, Aakre ME, West J, Moses HL, Owens P. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget 2015 June 11, 2015 PMID:26274893